glp-1 obesity drug news updates The next phase of the race Risks of Ozempic, other GLP-1

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.

This circadian rhythm is regulated by food intake..

It is designed to increase energy use and fat burning, not just suppress appetite

This interaction triggers multiple beneficial effects, such as enhancing insulin release from the pancreas when glucose levels are high, suppressing glucagon (which raises blood sugar), and signaling the brain to promote fullness

In earlier studies, retatrutide reduced liver fat by more than 80% in people with metabolic fatty liver disease, with most participants no longer meeting diagnostic thresholds

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.